GeneBioTech Co. Ltd (086060) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.072x

Based on the latest financial reports, GeneBioTech Co. Ltd (086060) has a cash flow conversion efficiency ratio of 0.072x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.87 Billion ≈ $2.62 Million USD) by net assets (₩54.03 Billion ≈ $36.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of GeneBioTech Co. Ltd to measure how much of total assets are equity-financed.

GeneBioTech Co. Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how GeneBioTech Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is GeneBioTech Co. Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.

GeneBioTech Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of GeneBioTech Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Katapult Holdings Inc NASDAQ:KPLT	-3.039x
Sunstone Metals Ltd AU:STM	-0.010x
Autech Corporation KQ:067170	-0.009x
North Energy ASA OL:NORTH	-0.013x
Kleannara KO:004540	0.132x
IBKS No. 15 Special Purpose Acquisition Co. Ltd. KQ:373200	-0.245x
Wijaya Karya Bangunan Gedung Tbk PT JK:WEGE	-0.007x
Hyungkuk F&B Co Ltd KQ:189980	0.069x

Annual Cash Flow Conversion Efficiency for GeneBioTech Co. Ltd (2009–2024)

The table below shows the annual cash flow conversion efficiency of GeneBioTech Co. Ltd from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of GeneBioTech Co. Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩50.97 Billion ≈ $34.54 Million	₩-463.87 Million ≈ $-314.36K	-0.009x	-105.97%
2023-12-31	₩48.30 Billion ≈ $32.74 Million	₩7.37 Billion ≈ $4.99 Million	0.153x	+289.60%
2022-12-31	₩45.73 Billion ≈ $30.99 Million	₩-3.68 Billion ≈ $-2.49 Million	-0.080x	-24.45%
2021-12-31	₩43.95 Billion ≈ $29.78 Million	₩-2.84 Billion ≈ $-1.93 Million	-0.065x	-216.88%
2020-12-31	₩45.04 Billion ≈ $30.52 Million	₩2.49 Billion ≈ $1.69 Million	0.055x	+196.80%
2019-12-31	₩46.93 Billion ≈ $31.80 Million	₩-2.68 Billion ≈ $-1.82 Million	-0.057x	-146.02%
2018-12-31	₩47.96 Billion ≈ $32.50 Million	₩5.96 Billion ≈ $4.04 Million	0.124x	+343.93%
2017-12-31	₩40.49 Billion ≈ $27.44 Million	₩1.13 Billion ≈ $767.40K	0.028x	-79.46%
2016-12-31	₩39.02 Billion ≈ $26.44 Million	₩5.31 Billion ≈ $3.60 Million	0.136x	+50.66%
2015-12-31	₩28.84 Billion ≈ $19.54 Million	₩2.61 Billion ≈ $1.77 Million	0.090x	-1.78%
2014-12-31	₩23.42 Billion ≈ $15.87 Million	₩2.15 Billion ≈ $1.46 Million	0.092x	-10.63%
2013-12-31	₩23.10 Billion ≈ $15.65 Million	₩2.38 Billion ≈ $1.61 Million	0.103x	-20.67%
2011-12-31	₩19.48 Billion ≈ $13.20 Million	₩2.53 Billion ≈ $1.71 Million	0.130x	+104.69%
2010-12-31	₩18.38 Billion ≈ $12.45 Million	₩1.17 Billion ≈ $789.56K	0.063x	-57.24%
2009-12-31	₩18.08 Billion ≈ $12.25 Million	₩2.68 Billion ≈ $1.82 Million	0.148x	--

About GeneBioTech Co. Ltd

KQ:086060 Korea Pharmaceuticals

Market Cap

$28.08 Million

₩41.43 Billion KRW

Market Cap Rank

#23915 Global

#1636 in Korea

Share Price

₩4950.00

Change (1 day)

+1.64%

52-Week Range

₩3600.00 - ₩5550.00

All Time High

₩10031.60